Formosa Laboratories Stock Fundamentals
| 4746 Stock | TWD 95.90 2.10 2.14% |
Formosa Laboratories fundamentals help investors to digest information that contributes to Formosa Laboratories' financial success or failures. It also enables traders to predict the movement of Formosa Stock. The fundamental analysis module provides a way to measure Formosa Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Formosa Laboratories stock.
Formosa |
Formosa Laboratories Company Current Valuation Analysis
Formosa Laboratories' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Formosa Laboratories Current Valuation | 9.7 B |
Most of Formosa Laboratories' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Formosa Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Formosa Laboratories has a Current Valuation of 9.7 B. This is 32.49% lower than that of the Pharmaceuticals sector and 30.42% higher than that of the Health Care industry. The current valuation for all Taiwan stocks is 41.67% higher than that of the company.
Formosa Laboratories Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Formosa Laboratories's current stock value. Our valuation model uses many indicators to compare Formosa Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Formosa Laboratories competition to find correlations between indicators driving Formosa Laboratories's intrinsic value. More Info.Formosa Laboratories is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Formosa Laboratories' earnings, one of the primary drivers of an investment's value.Formosa Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Formosa Laboratories' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Formosa Laboratories could also be used in its relative valuation, which is a method of valuing Formosa Laboratories by comparing valuation metrics of similar companies.Formosa Laboratories is currently under evaluation in current valuation category among its peers.
Formosa Fundamentals
| Return On Equity | -0.0393 | |||
| Return On Asset | 0.0034 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 9.7 B | |||
| Shares Outstanding | 120.26 M | |||
| Shares Owned By Insiders | 20.89 % | |||
| Shares Owned By Institutions | 4.64 % | |||
| Price To Earning | 97.70 X | |||
| Price To Book | 1.02 X | |||
| Price To Sales | 2.49 X | |||
| Revenue | 3.14 B | |||
| Gross Profit | 971.44 M | |||
| EBITDA | 1.59 B | |||
| Net Income | 1.25 B | |||
| Cash And Equivalents | 756.11 M | |||
| Cash Per Share | 7.64 X | |||
| Total Debt | 1.91 B | |||
| Debt To Equity | 78.60 % | |||
| Current Ratio | 1.93 X | |||
| Book Value Per Share | 60.24 X | |||
| Cash Flow From Operations | 311.16 M | |||
| Earnings Per Share | (1.85) X | |||
| Target Price | 40.1 | |||
| Number Of Employees | 23 | |||
| Beta | 0.86 | |||
| Market Capitalization | 8.08 B | |||
| Total Asset | 12.02 B | |||
| Retained Earnings | 680 M | |||
| Working Capital | 277 M | |||
| Current Asset | 2.31 B | |||
| Current Liabilities | 2.04 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 12.02 B | |||
| Last Dividend Paid | 2.0 |
About Formosa Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Formosa Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Formosa Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Formosa Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients and UV-filters worldwide. The company was founded in 1995 and is based in Taoyuan, Taiwan. FORMOSA LABORATORIES operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Formosa Stock Analysis
When running Formosa Laboratories' price analysis, check to measure Formosa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Formosa Laboratories is operating at the current time. Most of Formosa Laboratories' value examination focuses on studying past and present price action to predict the probability of Formosa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Formosa Laboratories' price. Additionally, you may evaluate how the addition of Formosa Laboratories to your portfolios can decrease your overall portfolio volatility.